Skip to main content
Abatacept reduced rates of progression to RA, phase 2b trial finds
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Abatacept reduced rates of progression to RA, phase 2b trial finds
User login
Username
Password
Reset your password
Concept
Lead
score
Rheumatoid Arthritis
1
0.94
Arthritis
0
0.8
UK Site Content
0
0.3
Cardiovascular Imaging
0
0.25
Anxiety Disorder
0
0.21
Adherence
0
0.2
Anxiety
0
0.2
Disease-Modifying Antirheumatic Drugs
0
0.2
Fatigue
0
0.2
Ultrasonography
0
0.2
Biologic Therapy
0
0.16
Arthralgia
0
0.1
Chronic Disease
0
0.1
Clinical Research
0
0.1
Corticosteroids
0
0.1
Costimulation
0
0.1
Depression
0
0.1
Grant
0
0.1
Healthcare and Medical Technology
0
0.1
Hospital
0
0.1
New York
0
0.1
Pregnancy
0
0.1
Sleep
0
0.1
Tissue Doppler Imaging
0
0.1
Vaccines
0
0.1
Specialty
Lead
score
Rheumatology
1
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Orthopaedics
0
0.94
Pharmacist
0
0.55
Psychiatry
0
0.38
Radiology
0
0.31
Public Health & Prevention
0
0.18
Ob/Gyn & Women's Health
0
0.16
Hospital Medicine
0
0.1
Nursing
0
0.1
Edit Tags